Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.42M 27.61M -63.69M -61.69M -65.44M -68.83M -65.77M -63.41M -61.58M -61.88M -60.51M -62.59M -135.2M -118.47M -110.09M -86.08M -1.88M -5.63M
Depreciation & Amortization
153K 200K 193K 190K 187K 181K 169K 171K 139K 123K 159K 185K 202K 177K 105K 35K 8.52K 8.76K
Stock-Based Compensation
15.72M 15.47M 17.38M 18.64M 12.59M 12.8M 11.95M 11.71M 11.42M 10.6M 9.64M 8.16M 6.05M 3.85M 2.11M 762K 148K 145.65K
Other Working Capital
7.12M 8.58M 7.98M 8.38M 5.17M 5.23M 11.46M 4.46M 1.57M 324K -7.36M -2.83M 148.79M 149M 188.36M 232.66M 81.16M 80.89M
Other Non-Cash Items
-97.64M -94.09M 2.41M 2.53M 9.4M 9.4M -787K -1.75M -2.02M -1.98M -833K 240K 568K 692K 836K 990K 1.81M 4.64M
Deferred Income Tax
n/a n/a n/a -380K -968K -1.83M -1.83M -1.45M -862K n/a n/a n/a 73.78M 71.21M 72.38M 72.53M -1.25M 1.32M
Change in Working Capital
-3.37M -563K -6.05M -3.63M 3.63M -319K -3.4M -6.6M -4.67M -2.12M -1.82M -473K -9.05M -9.86M 12.24M -1.5M 2.23M 1.85M
Operating Cash Flow
-95.56M -51.76M -59.55M -54.14M -50.41M -58.01M -59.66M -61.33M -57.57M -51.53M -49.64M -50.76M -59.94M -52.4M -22.42M -13.27M 1.07M 2.33M
Capital Expenditures
-926K -1.47M -1.65M -2.28M -3.19M -3.34M -3.97M -3.23M -2.24M -1.79M -444K -412K -310K -69K -46K 6.83K n/a -12.2K
Cash Acquisitions
101.36M 101.36M n/a -4.46M -18.23M -18.23M -35.93M 52.84M 66.6M 66.6M 84.3M n/a 25.36M 25.2M 25.2M 25.2M -157K n/a
Purchase of Investments
-68.7M -55.39M -63.04M -76.94M -67.94M -49.03M -64.44M -147.59M -168.24M -168.24M -145.19M -48.14M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
46.6M 59.09M 63.34M 68.38M 94.44M 129.81M 151.62M 146M 104.75M 53.5M 12.75M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
24.1M 21.07M 32.37M 36.83M 26.49M 80.77M 87.18M -1.59M -63.49M -114.74M -132.44M -48.14M -4.5M -4.5M -4.5M -4.49M 12.2K 12.2K
Investing Cash Flow
104.89M 130.15M 25.2M 15.72M 23.3M 77.43M 83.21M -4.82M -65.73M -116.53M -132.89M -48.55M 25.05M 25.13M 25.15M 25.22M -144.8K n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 194.37K
Common Stock Repurchased
118K 94K 94K 94K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.41M -4.41M -4.41M -4.41M n/a n/a
Other Financial Acitivies
-29.96M -29.02M -24.23M -24.2M 82K 308K 326K 139K 72.73M 72.33M 72.62M 72.81M 146.43M 146.51M 146.22M 146.13M -9.34M -9.34M
Financial Cash Flow
70.04M 70.98M -24.23M -24.2M 82K 308K 326K 139K 72.73M 72.33M 72.62M 72.81M 142.02M 142.1M 141.87M 141.93M 212.45K 407.81K
Net Cash Flow
103.73M 173.72M -34.22M -38.27M -27.02M 19.73M 23.87M -66.01M -50.58M -95.74M -109.91M -26.5M 107.13M 114.83M 144.53M 153.65M 910.56K 2.53M
Free Cash Flow
-96.49M -53.23M -61.2M -56.42M -53.6M -61.35M -63.63M -64.56M -59.81M -53.33M -50.08M -51.17M -60.25M -52.47M -22.47M -13.26M 1.07M 2.32M